AI and big data will be most impactful emerging technologies for pharma industry in 2023
The powerful duo can optimize a wide range of processes
According to a survey by GlobalData, 39% of the responding health care industry professionals believed AI would be the emerging technology bringing the greatest impact on the pharmaceutical industry in 2023, followed by big data with 27% of the selection.
GlobalData’s latest report, “The State of the Biopharmaceutical Industry - 2023,” reveals that AI and big data were trending as the two most disruptive emerging technologies since 2020, with a significant margin from the third choice in all four years.